Methylprednisolone is indicated for a wide range of acute and severe inflammatory and immune-mediated conditions, including allergic reactions, asthma exacerbations, autoimmune diseases, cerebral edema, and septic shock as adjunct therapy. In hospital and ICU settings, its key advantage is rapid and powerful anti-inflammatory and immunosuppressive effect, achieved through intravenous administration. It quickly stabilizes cell membranes, reduces cytokine release, and limits tissue damage in critical conditions. Methylprednisolone is particularly valuable when immediate control of inflammation is required, such as in acute respiratory distress, neurological emergencies, or severe hypersensitivity reactions. Its predictable response and flexibility in dosing make it an essential and widely trusted corticosteroid in emergency and intensive care practice.